The acquisition of Ordain Healthcare by global Insud Group led to the genesis and growth of Exeltis India. This strategic entry has created an ‘Indian subsidiary with a global soul’ that combines the best of the global group’s valuable know-how with the Indian operation's pioneering spirit. Thanks to this strategic amalgamation of two healthcare trailblazers, Exeltis India is now a global organisation that develops and markets a wide range of innovative products to meet the healthcare needs of millions. Exeltis India is backed by a robust manufacturing unit located near Chennai which comprises of 110+ employees. Driven by principles of quality and integrity, we aim to redefine healthcare in India .
The health and well-being of the people we serve are at the core of everything we do at Exeltis India. We are determined to develop therapeutic solutions that provide long-term value to people everywhere. Therefore we have an unwavering, non-negotiable commitment to ongoing innovation, product quality and human well-being.
Thanks to our entrepreneurial spirit, Exeltis India now has the capacity to develop, produce and deliver products that not only satisfy the unmet needs of patients but also improve their lives in substantial and tangible ways. Our unwavering commitment to find new therapeutic alternatives and medicinal products has prompted us to form strategic partnerships with other leading pharmaceutical companies. Our goal is to leverage these powerful synergies to make mutual progress and benefit all of humanity through healthcare.
To improve global health for everyone through innovative, affordable medicines
We offer global innovative solutions to deliver better health for everyone, devoting our passion, creativity and responsiveness to making the unimaginable possible
Acquires Ordain Healthcare, a south based pharmaceutical adept in specialty products.
2012
Acquires the infertility division (Fertica) from Alkem as a part of our consolidating the women healthcare portfolio.
2015
Acquires Klar Sehen,a Kolkata based pharmaceutical company specialized in ophthalmology
2016